Our finding that elevated hs-cTnT levels were associated with mortality at 3 months, but not with mortality or other outcomes at 6 or 12 months, is consistent with previous studies.[31,34]It seems likely that changes in hs-cTnT levels over time, rather than a single hs-cTnT level, may predict long-term prognosis after stroke. The gene discussed is TNNT2; the disease is stroke disorder.